Jazz Pharmaceuticals plc buy Barclays PLC
Start price
01.03.24
/
50%
€109.55
Target price
01.03.25
€212.20
Performance (%)
-6.62%
Price
26.04.24
€102.30
Summary
This prediction is currently active. With a performance of -6.62%, the BUY prediction by Barclays_PLC is trending in the wrong direction. This prediction currently runs until 01.03.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Jazz Pharmaceuticals plc | -0.872% | -0.872% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Barclays_PLC for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target lowered by analysts at Barclays PLC from $235.00 to $230.00. They now have an "overweight" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Barclays_PLC for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€116.60
29.01.24
29.01.24
€217.33
29.01.25
29.01.25
-12.26%
26.04.24
26.04.24
